InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (3 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Soparkar Peter, Executive. Director active across 1 company, notably Adverum Biotechnologies, Inc.. Aggregated, 9 reports have been recorded. Split: 3 buys · 3 sells. Total volume traded: €114k. Activity tracked since 6 August 2021. The latest transaction was filed on 15 May 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
2,960 shares@ US$2.004.6% of flowCommon StockSEC:0001415889-25-013446:0
13,125 shares0Common StockSEC:0001415889-25-005837:0
13,360 shares@ US$0.78168.5% of flowCommon StockSEC:0001209191-23-019839:0
13,305 shares@ US$1.069712.4% of flowCommon StockSEC:0001209191-22-050954:0
175 shares@ US$1.13730.2% of flowCommon StockSEC:0001209191-22-024977:0
Canonical exit: 18 Jul 2022 (T+90)
25,000 shares@ US$1.9137.1% of flowCommon StockSEC:0001209191-21-069098
Canonical exit: 8 Mar 2022 (T+90)
25,000 shares@ US$1.9149.9% of flowCommon StockSEC:0001209191-21-069098:0
Canonical exit: 8 Mar 2022 (T+90)
220,000 shares0Common StockSEC:0001209191-21-050748:0
220,000 shares0Common StockSEC:0001209191-21-050748
9 of 9 declarations
About Soparkar Peter
Peter Soparkar is an Executive at Adverum Biotechnologies, Inc. In this role, he participates in the strategic direction of the company. Soparkar brings valuable expertise in the sector, thereby contributing to informed decision-making and optimizing Adverum's performance. His commitment to operational excellence is an asset for the company.
